NCT01402089 2016-02-02Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer PatientsCantonal Hospital of St. GallenPhase 4 Completed54 enrolled